Evidence map›Paper›PMID 41462103›Full record

ArticleBMC anesthesiology2025

Back pain after atrial fibrillation ablation under propofol sedation with adaptive servo-ventilation: incidence, time course, efficacy of venous-closure devices, and related factors.

Haruna Sakanoue, Hirosuke Yamaji, Sayaka Okamoto, Kumi Okano, Yuka Fujita, Shunichi Higashiya, Takashi Murakami, Satoshi Hirohata, Shozo Kusachi

Abstract read
In one paragraph

Article in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haruna SakanoueDepartment of Nursing, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.
Hirosuke YamajiHeart Rhythm Center, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan. yamaji2@mac.com.
Sayaka OkamotoDepartment of Nursing, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.
Kumi OkanoDepartment of Nursing, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.
Yuka FujitaDepartment of Nursing, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.
Shunichi HigashiyaHeart Rhythm Center, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.
Takashi MurakamiHeart Rhythm Center, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.
Satoshi HirohataDepartment of Medical Technology, Okayama University Graduate School of Health Sciences, 2-5-1 Shikata-Cho, Kita-Ku, Okayama, 700-8558, Japan.
Shozo KusachiHeart Rhythm Center, Okayama Heart Clinic, Takeda 54-1, Naka-Ku, Okayama, 703-8251, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostoperative pain is a frequent but underrecognized complication following atrial fibrillation (AF) ablation. Although AF ablation is increasingly performed worldwide, non-cardiac complications, particularly musculoskeletal pain such as back pain, remain insufficiently investigated. Post-ablation back pain is commonly attributed to prolonged and rigid bed rest required to achieve hemostasis at the femoral venous puncture site. Venous-closure devices have recently been introduced, enabling earlier ambulation and less restrictive bed rest. We hypothesized that venous-closure device use is associated with a lower incidence of post-ablation back pain.

methodsWe retrospectively analyzed 615 consecutive patients who underwent AF ablation under deep propofol sedation with adaptive servo-ventilation at a single tertiary center. Hemostasis was achieved by either prolonged manual compression requiring overnight bed rest (conventional compression group, n = 312) or a venous-closure device allowing earlier mobilization (device-utilized group, n = 303). The incidence, timing, and temporal course of post-ablation back pain were systematically assessed. Multivariable regression analyses were performed to identify independent factors associated with back pain.

resultsBack pain occurred in 52.6% of patients in the conventional compression group. In contrast, the device-utilized group experienced significantly shorter enforced bed rest (3.4 ± 0.7 h vs. 18.0 ± 2.2 h) and a markedly lower incidence of back pain (23.4% vs. 52.6%, p < 0.001). Although the overall temporal pattern of pain onset was similar between groups, the incidence of back pain from the initiation of bed rest through the following morning was consistently lower in patients treated with a venous-closure device. Multivariable analysis identified younger age, absence of intraoperative pentazocine, a prior history of back pain, and non-use of a venous-closure device as independent factors associated with post-ablation back pain.

conclusionsPost-ablation back pain occurred in nearly half of patients undergoing AF ablation with conventional manual compression. Venous-closure device use was independently associated with a substantially lower incidence of back pain, likely through earlier and less restrictive mobilization. Nevertheless, back pain persisted in approximately one-quarter of patients despite device use, indicating a need for additional preventive strategies.

Indexed as

Atrial FibrillationBack PainCatheter AblationDeep SedationPostoperative PainPropofolVascular Closure DevicesAgedBed RestFemaleHumansHypnotics and SedativesIncidenceMaleMiddle AgedRetrospective StudiesHypnotics and SedativesPropofolAtrial fibrillationBed restCatheter ablationPostoperative painSedationVenous-closure device

Identifiers

PMID41462103
PMCPMC12860140

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.